Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology.

[1]  W. P. Glezen,et al.  Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. , 1987, The American review of respiratory disease.

[2]  B. Murphy,et al.  Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus , 1986, Journal of clinical microbiology.

[3]  J. Mullooly,et al.  Impact of epidemic type A influenza in a defined adult population. , 1980, American journal of epidemiology.

[4]  E. D. Kilbourne,et al.  Influenza in Man , 1987 .

[5]  B. Psaty,et al.  Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. , 2002, American journal of epidemiology.

[6]  Malbea A Lapete,et al.  Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2004 .

[7]  E. Gurfinkel,et al.  Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. , 2004, European heart journal.

[8]  R. Hubbard,et al.  Risk of myocardial infarction and stroke after acute infection or vaccination. , 2004, The New England journal of medicine.

[9]  D. Taira,et al.  Influenza Vaccination, Hospitalizations, and Costs Among Members of a Medicare Managed Care Plan , 2001, Medical care.

[10]  L. Simonsen,et al.  Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. , 1998, The Journal of infectious diseases.

[11]  P. Ubel,et al.  Barriers to influenza immunization in a low-income urban population. , 2001, American journal of preventive medicine.

[12]  S. Clark,et al.  National availability of influenza vaccine among medical subspecialty practices. , 2004, American journal of preventive medicine.

[13]  Keiji Fukuda,et al.  Influenza-associated hospitalizations in the United States. , 2004, JAMA.

[14]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[15]  S. Schappert,et al.  Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. , 1997, Vital and health statistics. Series 13, Data from the National Health Survey.

[16]  E. Gurfinkel,et al.  Influenza Vaccine Pilot Study in Acute Coronary Syndromes and Planned Percutaneous Coronary Interventions: The FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study , 2002, Circulation.

[17]  S. Clark,et al.  A national survey of physician practices regarding influenza vaccine , 2002, Journal of General Internal Medicine.

[18]  E. Gurfinkel,et al.  Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry. , 2004, Texas Heart Institute journal.

[19]  C. Burt,et al.  Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1999--2000. , 2004, Vital and health statistics. Series 13, Data from the National Health Survey.

[20]  M. Pfeffer,et al.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. , 2006, Circulation.

[21]  C. Burt,et al.  Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. , 2006, Vital and health statistics. Series 13, Data from the National Health Survey.

[22]  J. Mullooly,et al.  Pneumonia and influenza deaths during epidemics: implications for prevention. , 1982, Archives of internal medicine.

[23]  R. Strikas,et al.  Influenza, pneumococcal, and tetanus toxioid vaccination of adults--United States, 1993-7. , 2000, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[24]  Steven A. Smith,et al.  Use of influenza and pneumococcal vaccines in people with diabetes. , 2000, Diabetes care.

[25]  T. Raghunathan,et al.  Influenza vaccination and the risk of primary cardiac arrest. , 2000, American journal of epidemiology.

[26]  D. Grabli,et al.  Association Between Influenza Vaccination and Reduced Risk of Brain Infarction , 2002, Stroke.

[27]  T. Strine,et al.  Low prevalence of influenza vaccination among people with cardiovascular disease--BRFSS. , 2005, American journal of preventive medicine.

[28]  C. Bridges,et al.  Influenza Vaccination of Health-Care Personnel Recommendations of the Healthcare Infection Control Practices Advisory Committee ( HICPAC ) and the Advisory Committee on Immunization Practices ( ACIP ) , 2006 .

[29]  K. Nichol,et al.  Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. , 1998, Archives of internal medicine.

[30]  Kingston H. Tseng,et al.  Standards of Medical Care in Diabetes–2006 , 2006, Diabetes Care.

[31]  A. Kendal,et al.  Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. , 1987, American journal of public health.

[32]  M. Naghavi,et al.  Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction , 2000, Circulation.

[33]  Matthew M Davis,et al.  Delivery of Influenza Vaccine to Nonelderly Persons with Cardiovascular Disease, with Varying National Supply of Vaccine: A Decision Analysis , 2005, Human vaccines.

[34]  V. Gurevich,et al.  Autoimmune Nature of Influenza Atherogenicity , 2005, Annals of the New York Academy of Sciences.

[35]  U. Bauer,et al.  [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.

[36]  M. Pfeffer,et al.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.